Introduction
Cancer is a complex disease in which cells with altered as CIN tumors. [1] [2] [3] Various reports indicate a significant increase in the chromosomal aberrations (CAs) in peripheral blood lymphocytes (PBLs) of cancer patients with solid tumors. [4] [5] [6] [7] PBLs of patients with breast cancer and other solid tumors show simple chromosomal lesions that may be stable markers in cancer cells. [8] Hence, it is proposed that lymphocytes may be used as a surrogate tissue model for studying genomic instability in case of solid tumors and the frequency of CAs in PBLs can be used as a predictor of cancer risk. [9] [10] [11] [12] Breast cancer is a major global health problem and the incidence of the disease continues to increase steadily. Table 1 ]. Control subjects were in the age group of 27-66 years. Fifty-five percent (n = 11) of the controls belonged to urban areas, 20% (n = 4) of them were from suburban areas, and 25%
(n = 5) belonged to rural area. Most (90%) (n = 18) of them consumed vegetarian diet [ Table 1 ].
The frequency of aberrant metaphases varied from 3.3 to 60.1% in cultured lymphocytes of patients and from 1.5 to 5.7% in controls [ Table 2 A statistically significant difference in the percentage of aberrant metaphases was seen among patients and controls (t-value = 10.1, P < 0.001).
Discussion
Genetic instability is a defining feature of human cancer. In the present study, breast cancer patients had where genomic instability has been correlated with tumor progression. Genomic instability has been found to be low in benign and hyperplastic tissues, but dramatically increased in ductal carcinoma and invasive cancer. [15] Frequency of allelic imbalance (or MIN) in tumor tissue has been shown to be significantly correlated with tumor progression in colorectal cancer. [16] In a fluorescent in situ hybridization study of numerical alterations of chromosomes 7, 8, 16 , and 17 in 28 ductal carcinoma in situ (DCIS), it was shown that the patterns of aneuploidy in breast tumor tissue may differ according to the tumor grade. [17] This indicated that lymphocytic CIN was an index of inherent instability in the patient's genome and was not influenced by the disease status, whereas genomic instability of the tumor could be influenced by the patient's disease status or aggressiveness of tumor.
High frequency of aberrations in PBLs of breast cancer patients similar to that seen in tumor tissue has already been reported in several studies. [12, [18] [19] [20] Also, greater than expected infrared-induced genomic instability has been seen in lymphocytes of patients with breast cancer and other solid tumors. [21] [22] [23] Thus, cancer patients probably have constitutional CIN, which participates in cancer predisposition.
Aberrations involving specific chromosomes (2, 7, 11, 12, 15, 19, 22 , and X) in the lymphocytes of breast cancer patients have been reported in a previous study. [20] Various genes involved in genomic stability and breast tumorigenesis [EP300 (22q13. [ 24] Another interesting observation from the analysis of epidemiological data of the patients was that many of the well-established epidemiological risk factors reported in previous studies on western data (i.e., late age of menopause, early age of menarche, nulliparity, older age at first birth, alcohol consumption, high meat intake, and high socioeconomic status [25, 26] ) did not account for the etiology of the disease in patients in the present study. Early age at menarche (less than 12 years of age)
has been associated with a 10-20% increase in breast cancer risk and delayed menopause (after 54 years of age) maximizes the number of ovulatory cycles, leading to increased breast cancer risk. [27] [28] [29] Nulliparity and late age at first birth also contribute toward an increased risk of developing breast cancer. [25] In the present study, most of the patients had a normal reproductive and menstrual history. The age at menarche of the patients varied from 12 to 16 years and age at menopause was between 43
and 55 years. Most of them consumed a vegetarian diet and none of them reported alcohol consumption. Thus, some genetic and environmental factors might be acting synergistically and are responsible for the high incidence of breast cancer in this area. Amritsar has many small-scale industries, such as textile processing, woolen, dyeing, electroplating, pharmaceutical, iron foundaries, pulp and paper mills, steel plants, dairy, and glass and plastic mills, and the area adjoining the city is mainly agricultural land, where the use of pesticides and agricultural chemicals is high. Heavy metal contamination has also been reported in agricultural products, soil, and water in and around Amritsar (www.punjabenvironment.com).
In the present study, the patients had much higher CIN than controls. Even patients with benign disease or at stage I had higher CIN than controls. But, the patients had variation in the level of CIN in PBLs with no apparent correlation with disease stage, as a stage I patient had up to 60% aberrant metaphases while a stage II patient had only 3.3% aberrant metaphases. The present study is in agreement with the previous reports on validity of cytogenetic assay for determination of frequency of CAs as a biomarker for cancer risk. [8] [9] [10] [11] Such studies had been subject to criticism due to not accounting for the reverse causality bias, i.e. when the biomarker might be affected by the disease. But, the present study suggests an independence of this biomarker from disease stage. The inherent difference in the level of genomic instability might play a significant role in disease progression, patient tolerance for radiation and antineoplastic agents, and recurrence risk. Breast cancer (BRCA) proteins and their associated molecules (e.g., Fanconi anemia proteins, Ataxia telangiectasia mutated-Ras-associated diabetes (ATM-RAD complex) work in a network of connected biological complexes that encompass virtually all aspects of the cellular response to DNA damage during the S and G2 phases of the cell cycle. [30] Cells lacking these proteins fail to correct endogenous DNA damage during or after DNA synthesis. Individuals with mutation in BRCA or associated proteins show sensitivity to DNA cross-linking agents such as cisplatin and mitomycin C. Determination of the genomic instability level of individual patients before planning therapy may help avoid tissue and cellular damage by radiation and cancer chemotherapy drugs by permitting lessaggressive therapy of the sensitive patients.
